- Home
- MACI vs CATX Comparison
MACI vs CATX Comparison
Compare MACI & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MACI
- CATX
- Stock Information
- Founded
- MACI 2024
- CATX 1983
- Country
- MACI United States
- CATX United States
- Employees
- MACI N/A
- CATX N/A
- Industry
- MACI
- CATX Medical/Dental Instruments
- Sector
- MACI
- CATX Health Care
- Exchange
- MACI NYSE
- CATX Nasdaq
- Market Cap
- MACI 221.6M
- CATX 182.9M
- IPO Year
- MACI 2024
- CATX N/A
- Fundamental
- Price
- MACI $10.37
- CATX $2.57
- Analyst Decision
- MACI
- CATX Strong Buy
- Analyst Count
- MACI 0
- CATX 9
- Target Price
- MACI N/A
- CATX $12.63
- AVG Volume (30 Days)
- MACI 9.4K
- CATX 749.8K
- Earning Date
- MACI 01-01-0001
- CATX 05-12-2025
- Dividend Yield
- MACI N/A
- CATX N/A
- EPS Growth
- MACI N/A
- CATX N/A
- EPS
- MACI 0.33
- CATX N/A
- Revenue
- MACI N/A
- CATX $1,471,000.00
- Revenue This Year
- MACI N/A
- CATX N/A
- Revenue Next Year
- MACI N/A
- CATX N/A
- P/E Ratio
- MACI $31.51
- CATX N/A
- Revenue Growth
- MACI N/A
- CATX N/A
- 52 Week Low
- MACI $9.95
- CATX $1.60
- 52 Week High
- MACI $10.40
- CATX $16.55
- Technical
- Relative Strength Index (RSI)
- MACI N/A
- CATX 53.32
- Support Level
- MACI N/A
- CATX $2.34
- Resistance Level
- MACI N/A
- CATX $2.94
- Average True Range (ATR)
- MACI 0.00
- CATX 0.28
- MACD
- MACI 0.00
- CATX 0.00
- Stochastic Oscillator
- MACI 0.00
- CATX 55.95
About MACI MELAR ACQUISITION CORP. I
Melar Acquisition Corp I is a blank check company.
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.